Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AemetisAMTX +1.91%36 Cash-to-Debt is 0.00 as of Jun. 2026. GuruFocus rates AMTX with a GF Score™ of 36/100 and a GF Value™ of $1.88 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 1,590 Chemicals companies, Aemetis ranks worse than 62893.02% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Aemetis's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.00.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Aemetiscouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Aemetis's Cash-to-Debt or its related term are showing as below:
During the past 13 years, Aemetis's highest Cash to Debt Ratio was 0.08. The lowest was 0.00. And the median was 0.01.
AMTX's Cash-to-Debt is not ranked *
in the Chemicals industry.
Industry Median: 0.67 * Ranked among companies with meaningful Cash-to-Debt only.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Aemetis Cash-to-Debt Related Terms
Aemetis Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Aemetis's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Specialty Chemicals subindustry, Aemetis's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aemetis Cash-to-Debt vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Aemetis's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Aemetis's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aemetis (AMTX) has a Cash-to-Debt of 0.00 as of Jun. 2026. According to the industry distribution chart, Aemetis ranks #999999 out of 1590 companies in the Chemicals industry.
Is Aemetis' Cash-to-Debt too high?
Aemetis' current Cash-to-Debt is 0.00. Based on the distribution chart, Aemetis ranks #999999 out of 1590 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Aemetis has a GF Score™ of 36/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aemetis' Cash-to-Debt compare to KBLB and NTIC?
According to the Chemicals industry distribution chart, Aemetis ranks #999999 out of 1590 companies for Cash-to-Debt. This places Aemetis in the lower half of its industry. The industry median Cash-to-Debt is 0.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Chemicals company?
The median Cash-to-Debt among Chemicals companies is 0.67, based on 1,590 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median Cash-to-Debt is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aemetis's current Cash-to-Debt is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aemetis stock overvalued right now?
Based on GuruFocus' analysis, Aemetis (AMTX) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.88, compared to a current price of $2.13 — trading 13.3% above its estimated fair value. The current Cash-to-Debt is 0.00. Aemetis' overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Aemetis (AMTX), the current Cash-to-Debt is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aemetis (AMTX) Overvalued in 2026?
Based on GuruFocus' analysis, Aemetis stock appears to be overvalued.
The current stock price of $2.13 is trading 13.3% above its estimated GF Value™ of $1.88.
GuruFocus considers Aemetis to be Modestly Overvalued.
Key valuation signals for AMTX:
Cash-to-Debt: 0.00
GF Value™: $1.88 vs. price of $2.13 (13.3% above fair value)
No single metric tells the full story. See the AMTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.
36GF Score
Get the complete analysis for AMTX
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMTX has been successfully added to your 
